rs781279282
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_Strong
The NM_002156.5(HSPD1):c.1219G>A(p.Gly407Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,461,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002156.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 13Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hypomyelinating leukodystrophy 4Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HSPD1 | NM_002156.5 | c.1219G>A | p.Gly407Ser | missense_variant | Exon 10 of 12 | ENST00000388968.8 | NP_002147.2 | |
| HSPD1 | NM_199440.2 | c.1219G>A | p.Gly407Ser | missense_variant | Exon 10 of 12 | NP_955472.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250886 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461086Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 726906 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with HSPD1-related disease. This variant is present in population databases (rs781279282, ExAC 0.003%). This sequence change replaces glycine with serine at codon 407 of the HSPD1 protein (p.Gly407Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. -
not provided Uncertain:1
HSPD1: PP3 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at